A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer

Background: Current staging systems are inadequate for evaluating the prognosis of patients with locally advanced gastric cancer (LAGC, stages II–III). Therefore, we developed a serum microRNA (miRNA) signature to facilitate individualized management of these patients. Methods: Using microarray anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shangxiang, Lao, Jiawen, Geng, Qirong, Zhang, Ji, Wu, Aiwen, Xu, Dazhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323914/
https://www.ncbi.nlm.nih.gov/pubmed/32656071
http://dx.doi.org/10.3389/fonc.2020.00565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323914/
https://www.ncbi.nlm.nih.gov/pubmed/32656071
http://dx.doi.org/10.3389/fonc.2020.00565

Ejemplares similares